Idiopathic myelofibrosis : a clinical study of 80 patientsHASSELBALCH, H.American journal of hematology. 1990, Vol 34, Num 4, pp 291-300, issn 0361-8609, 10 p.Article

Case report: remission of chronic idiopathic myelofibrosis to busulfan treatmentCHANG, J. C; GROSS, H. M.The American journal of the medical sciences. 1988, Vol 295, Num 5, pp 472-476, issn 0002-9629Article

Marrow fibrosis in myeloma: improvement by alkylatingPATTERSON, K. G; TRELEAVEN, J. G; ZUIABLE, A et al.Clinical and laboratory haematology. 1988, Vol 10, Num 2, pp 221-224, issn 0141-9854Article

Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significanceHASSELBALCH, H; ANKER JENSEN, B.European journal of haematology. 1990, Vol 44, Num 3, pp 172-178, issn 0902-4441Article

Megakaryocytes and myelofibrosis in gray platelet syndromeCAEN, J. P; DESCHAMPS, J. F; BODEVIN, E et al.Nouvelle revue française d'hématologie. 1987, Vol 29, Num 2, pp 109-114, issn 0029-4810Article

Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesisBEGUIN, Y; FILLET, G; BURY, J et al.American journal of hematology. 1989, Vol 32, Num 2, pp 123-128, issn 0361-8609Article

Platelet-derived growth factor is decreased in patients with myeloproliferative disordersKATOH, O; KIMURA, A; KURAMOTO, A et al.American journal of hematology. 1988, Vol 27, Num 4, pp 276-280, issn 0361-8609Article

The usefulness of 1,25-dihydroxy-vitamin D₃ (1,25(OH)₂ vit D₃) in the treatment of idiopathic myelofibrosisRICHARD, C; MAZORRA, F; IRIONDO, A et al.British journal of haematology. 1986, Vol 62, Num 2, pp 399-400, issn 0007-1048Article

Idiopathic myelofibrosis : a reviewHASSELBALCH, H.European journal of haematology. 1990, Vol 45, Num 2, pp 65-72, issn 0902-4441, 8 p.Article

Platelet-derived mitogenic acitivity and bone marrow fibrosis in myeloproliferative disordersROMANO, M; VIERO, P; CORTELLAZZO, S et al.Haemostasis. 1990, Vol 20, Num 3, pp 162-168, issn 0301-0147Article

A prognostic classification of myelofibrosis with myeloid metaplasiaBAROSI, G; BERZUINI, C; LIBERATO, L. N et al.British journal of haematology. 1988, Vol 70, Num 4, pp 397-401, issn 0007-1048Article

Myélofibrose du nourrisson régressive sous corticothérapie et immunoglobulines intraveineuses = Myelofibrosis of the infant regressive with corticosteroid and intravenous immunoglobulin therapyPILORGET, H; BANGUI, A; ADAM, M et al.Archives de pédiatrie (Paris). 1996, Vol 3, Num 1, pp 40-43, issn 0929-693XArticle

Spurious hyperkalaemia associated with severe thrombocytosis and leukocytosisHO, A. M.-H; WOO, J. C. H; KELTON, J. G et al.Canadian journal of anaesthesia. 1991, Vol 38, Num 5, pp 613-615, issn 0832-610XArticle

Myélofibrose aiguë maligne : rapport de trois casJOUNDI, A; CAULET, T; CAULET, S et al.Archives d'anatomie et de cytologie pathologiques. 1991, Vol 39, Num 3, pp 103-108, issn 0395-501XArticle

La myelofibrose = MyelofibrosisDEMORY, J.-L.Lille médical (1987). 1988, Vol 28, Num 4, pp 147-151Article

Liver dysfunction following splenectomy in idiopathic myelofibrosis : a study of 10 patientsLOPEZ-GUILLERMO, A; CERVANTES, F; BRUGUERA, M et al.Acta haematologica. 1991, Vol 85, Num 4, pp 184-188, issn 0001-5792Article

Acute myelofibrosis : a leukemia of pluripotent stem cell : a report of three cases and review of the literatureAMBERGER, D. M; SALEEM, A; KEMP, B. L et al.Annals of clinical and laboratory science. 1990, Vol 20, Num 6, pp 409-414, issn 0091-7370Article

Marrow fibrosis and multiple myelomaKRZYZANIAK, R. L; BUSS, D. H; COOPER, M. R et al.American journal of clinical pathology. 1988, Vol 89, Num 1, pp 63-68, issn 0002-9173Article

Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasiaWOLF, B. C; NEIMAN, R. S.Hematologic pathology. 1987, Vol 1, Num 1, pp 77-80, issn 0886-0238Article

Idiopathic myelofibrosis terminating in erythroleukemiaGARCIA, S; MIGUEL, A; MIGUEL, A et al.MIGUEL, A; MIGUEL, A et al.American journal of hematology. 1989, Vol 32, Num 1, pp 70-71, issn 0361-8609Article

Possible and up to now not exploited treatment in myelofibrosisBERANEK, J. T.British journal of haematology. 1988, Vol 68, Num 1, issn 0007-1048, 144Article

Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyureaLOFVENBERG, E; WAHLIN, A.European journal of haematology. 1988, Vol 41, Num 4, pp 375-381, issn 0902-4441Article

Case report osteolytic lesions in idiopathic myelofibrosisGRUBER, A; ÖSBY, E.Medical oncology and tumor pharmacotherapy. 1987, Vol 4, Num 2, pp 107-109, issn 0736-0118Article

Increased vascularity of bone marrow in myelofibrosisCHARBORD, P.British journal of haematology. 1986, Vol 62, Num 3, pp 595-596, issn 0007-1048Article

Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathyBRENNER, B; GREEN, J; ROSENBAUM, H et al.Acta haematologica. 1985, Vol 74, Num 1, pp 43-44, issn 0001-5792Article